OTC Markets OTCQB - Delayed Quote USD

Can B Corp. (CANB)

Compare
0.0400 +0.0080 (+25.00%)
As of 10:50 AM EDT. Market Open.
Loading Chart for CANB
DELL
  • Previous Close 0.0320
  • Open 0.0350
  • Bid 0.0360 x --
  • Ask 0.0400 x --
  • Day's Range 0.0350 - 0.0400
  • 52 Week Range 0.0030 - 0.1700
  • Volume 326,213
  • Avg. Volume 166,131
  • Market Cap (intraday) 2.546M
  • Beta (5Y Monthly) 1.26
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2300
  • Earnings Date Nov 18, 2024 - Nov 22, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Can B Corp. develops, manufactures, and sells hemp biomass derived products containing cannabinoids. The company provides hemp cannabinoid products, including oils, creams, moisturizers, isolate, gel caps, spa products, concentrates, and lifestyle products. It sells its products under the Canbiola and Pure Leaf Oil brands through medical professionals under distribution agreements and its website. The company also produces industrial hemp, and processes hemp biomass, isolate, and isomers, such as CBN, CBG, delta-8, and delta-10; and manufactures and sells durable medical equipment. The company was formerly known as Canbiola Inc. and changed its name to Can B Corp. in January 2020. Can B Corp. was incorporated in 2005 and is based in Hicksville, New York.

www.canbcorp.com

12

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CANB

View More

Performance Overview: CANB

Trailing total returns as of 10/30/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CANB
48.15%
S&P 500
22.44%

1-Year Return

CANB
2.44%
S&P 500
41.84%

3-Year Return

CANB
99.56%
S&P 500
26.81%

5-Year Return

CANB
99.95%
S&P 500
92.31%

Compare To: CANB

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CANB

View More

Valuation Measures

Annual
As of 10/29/2024
  • Market Cap

    2.04M

  • Enterprise Value

    18.75M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.73

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    13.05

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -52.65%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    1.44M

  • Net Income Avi to Common (ttm)

    -14.16M

  • Diluted EPS (ttm)

    -0.2300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    2.07M

Research Analysis: CANB

View More

Revenue vs. Earnings

Revenue 272.29k
Earnings -2.03M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Company Insights: CANB

People Also Watch